BioRestorative Therapies, Inc. 4
4 · BioRestorative Therapies, Inc. · Filed Feb 15, 2017
Insider Transaction Report
Form 4
Tonna Paul Jude
Director
Transactions
- Award
Option
2017-02-14+15,000→ 15,000 totalExercise: $4.70Exp: 2024-06-27→ Common Stock (15,000 underlying) - Award
Option
2017-02-14+60,000→ 60,000 totalExercise: $4.70Exp: 2025-09-04→ Common Stock (60,000 underlying) - Award
Option
2017-02-14+25,000→ 25,000 totalExercise: $4.70Exp: 2024-10-23→ Common Stock (25,000 underlying) - Disposition to Issuer
Option
2017-02-14−15,000→ 0 totalExercise: $5.70Exp: 2024-06-27→ Common Stock (15,000 underlying) - Disposition to Issuer
Option
2017-02-14−25,000→ 0 totalExercise: $6.60Exp: 2024-10-23→ Common Stock (25,000 underlying) - Disposition to Issuer
Option
2017-02-14−60,000→ 0 totalExercise: $7.00Exp: 2025-09-04→ Common Stock (60,000 underlying)
Holdings
- 100
Warrant
Exercise: $15.00From: 2014-08-01Exp: 2019-07-31→ Common Stock (100 underlying) - 6,000
Common Stock
- 1,400
Warrant
Exercise: $15.00From: 2014-08-01Exp: 2019-07-11→ Common Stock (1,400 underlying) - 64,000
Option
Exercise: $3.73Exp: 2026-06-10→ Common Stock (64,000 underlying)
Footnotes (6)
- [F1]Owned jointly with wife.
- [F2]The option vests to the extent of 5,000 shares on each of June 27, 2014, June 27, 2015 and June 27, 2016.
- [F3]The option is exercisable to the extent of 8,334 shares on October 23, 2015 and 8,333 shares on each of October 23, 2016 and October 23, 2017.
- [F4]The option is exercisable to the extent of 30,000 shares on December 22, 2015 and 10,000 shares on each of September 4, 2016, September 4, 2017 and September 4, 2018.
- [F5]The option is exercisable to the extent of 21,334 shares on June 10, 2016, and 21,333 shares on each of June 10, 2017 and June 10, 2018.
- [F6]The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price.